StonvexLoading…
StonvexStonvexStonvexCore line items from NDLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-11 | Q1 2026 2026-03-31 | Annual 2025 2025-12-30 | Q3 2025 2025-09-30 | Q3 2025 2025-07-01 |
|---|---|---|---|---|---|
Revenue | $121.79M | $123.79M | $495.09M | $372.31M | $250.23M |
Operating Income | Not available | $-812.00K | $-31.59M | $-27.48M | $-21.16M |
Net Income | Not available | $-3.42M | $-42.57M | $-35.76M | $-26.61M |
EPS (Diluted) | $-0.05 | $-0.58 | $-7.36 | $-0.78 | $-0.58 |
Total Assets | Not available | $246.31M | $261.67M | $280.57M | $294.57M |
Total Liabilities | Not available | $294.36M | $306.98M | $319.47M | $325.35M |
Cash & Equivalents | Not available | $1.44M | $1.26M | $4.69M | $2.26M |
Free Cash Flow OCF − CapEx | Not available | $3.94M | $-5.11M | $-1.70M | $-3.14M |
Shares Outstanding | Not available | 5.89M | 5.85M | 46.77M | 46.43M |